01 6Gilead Sciences Canada Inc.
01 22406278
02 22463294
03 22566609
01 6IDELALISIB
01 6TABLET
01 22021-04-24
02 22022-08-27
03 22025-05-12
Patent Expiration Date : 2025-05-12
Date Granted : 2012-06-26
Brand Name : ZYDELIG?
Patent Number : 2566609
Filing Date : 2005-05-12
Strength per Unit : 100 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2025-05-12
Date Granted : 2012-06-26
Patent Expiration Date : 2022-08-27
Date Granted : 2009-04-07
Brand Name : ZYDELIG?
Patent Number : 2463294
Filing Date : 2002-08-27
Strength per Unit : 100 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2022-08-27
Date Granted : 2009-04-07
Patent Expiration Date : 2021-04-24
Date Granted : 2012-06-05
Brand Name : ZYDELIG?
Patent Number : 2406278
Filing Date : 2001-04-24
Strength per Unit : 100 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2021-04-24
Date Granted : 2012-06-05
Patent Expiration Date : 2021-04-24
Date Granted : 2012-06-05
Brand Name : ZYDELIG?
Patent Number : 2406278
Filing Date : 2001-04-24
Strength per Unit : 150 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2021-04-24
Date Granted : 2012-06-05
Patent Expiration Date : 2022-08-27
Date Granted : 2009-04-07
Brand Name : ZYDELIG?
Patent Number : 2463294
Filing Date : 2002-08-27
Strength per Unit : 150 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2022-08-27
Date Granted : 2009-04-07
Patent Expiration Date : 2025-05-12
Date Granted : 2012-06-26
Brand Name : ZYDELIG?
Patent Number : 2566609
Filing Date : 2005-05-12
Strength per Unit : 150 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2025-05-12
Date Granted : 2012-06-26
